| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6121183 | Journal of Clinical Virology | 2013 | 5 Pages |
Abstract
The data suggest that BK-PyVHC may be the result of nosocomial transmission in children with low/undetectable BKV antibodies and raises urgent questions about appropriate infection control measures and the role of cidofovir.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Minna Koskenvuo, Alexis Dumoulin, Irmeli Lautenschlager, Eeva Auvinen, Laura Mannonen, Veli-Jukka Anttila, Kirsi Jahnukainen, Ulla M. Saarinen-Pihkala, Hans H. Hirsch,